The administration of bortezomib and lenalidomide resulted in the reduction of VCAM-1 and ICAM-1 and supports an inhibitory effect of these drugs on the adhesion of MM cells to stromal cells. The gene discussed is ICAM1; the disease is Miyoshi myopathy.